SCHEMBL4604004

SCHEMBL4604004

C[C@H](N)CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL636641 1.00
SCHEMBL638004 1.00
Hydrochloric Acid SCHEMBL385419 0.97
Hydrochloric Acid SCHEMBL31008508 0.97
Hydrochloric Acid SCHEMBL6044576 0.97
Hydrochloric Acid SCHEMBL385418 0.97
Hydrochloric Acid SCHEMBL30958967 0.97 GABRP (0.40)
SCHEMBL12132306 0.78 GABRP (0.36)
SCHEMBL10140608 0.78 GABRP (0.36)
SCHEMBL13050663 0.78 GABRP (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119432794-A Process for preparing (S) -3-aminobutyric acid by transaminase catalysis 宁波酶赛生物工程有限公司 2025-02-14 CN claimed
CN-119431184-A Synthesis method of (S) -3-aminobutyric acid 宁波酶赛生物工程有限公司 2025-02-14 CN claimed
US-12473295-B2 Substituted straight chain spiro derivatives JANSSEN PHARMACEUTICA NV (BE) 2025-11-18 US disclosed
CN-119431184-A Synthesis method of (S) -3-aminobutyric acid 宁波酶赛生物工程有限公司 2025-02-14 CN disclosed
CN-119431184-A Synthesis method of (S) -3-aminobutyric acid 宁波酶赛生物工程有限公司 2025-02-14 CN disclosed
CN-119432794-A Process for preparing (S) -3-aminobutyric acid by transaminase catalysis 宁波酶赛生物工程有限公司 2025-02-14 CN disclosed
CN-119432794-A Process for preparing (S) -3-aminobutyric acid by transaminase catalysis 宁波酶赛生物工程有限公司 2025-02-14 CN disclosed
US-20230142285-A1 SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
CN-111848483-B Asymmetric catalytic preparation method of brivaracetam 南方科技大学 2022-09-23 CN disclosed
EP-3177616-B1 NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT SANDOZ AG (CH) 2021-02-24 EP disclosed
CN-111848483-A Asymmetric catalytic preparation method of brivaracetam 南方科技大学 2020-10-30 CN disclosed
EP-3041468-B1 CYCLIC PEPTIDOMIMETIC COMPOUNDS AS IMMUNOMODULATORS AURIGENE DISCOVERY TECH LTD (IN) 2018-06-13 EP disclosed
EP-2809655-B1 BENZIIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS SODIUM CHANNEL MODULATORS PFIZER (US) 2015-08-12 EP disclosed
US-8927587-B2 Chemical compounds PFIZER LIMITED (GB) 2015-01-06 US disclosed
US-20130274243-A1 Chemical Compounds PFIZER LTD (GB) 2013-10-17 US disclosed
US-7456194-B2 Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 US disclosed
EP-1768978-B1 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-07-09 EP disclosed
US-20080058332-A1 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer ASTRAZENECA AB (SE) 2008-03-06 US disclosed